SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-001788
Filing Date
2022-03-21
Accepted
2022-03-21 07:46:38
Documents
51
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K sunshine_i10k-123121.htm   iXBRL 10-K 816366
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES sunshine_ex0401.htm EX-4.1 14573
3 CERTIFICATION sunshine_ex3101.htm EX-31.1 8239
4 CERTIFICATION sunshine_ex3102.htm EX-31.2 8236
5 CERTIFICATION sunshine_ex3201.htm EX-32.1 3670
6 GRAPHIC image_007.jpg GRAPHIC 11849
7 GRAPHIC image_008.jpg GRAPHIC 13466
8 GRAPHIC image_009.jpg GRAPHIC 18576
9 GRAPHIC image_010.jpg GRAPHIC 9687
  Complete submission text file 0001683168-22-001788.txt   3777330

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE sbfm-20211231.xsd EX-101.SCH 23340
11 XBRL CALCULATION FILE sbfm-20211231_cal.xml EX-101.CAL 41180
12 XBRL DEFINITION FILE sbfm-20211231_def.xml EX-101.DEF 103203
13 XBRL LABEL FILE sbfm-20211231_lab.xml EX-101.LAB 202773
14 XBRL PRESENTATION FILE sbfm-20211231_pre.xml EX-101.PRE 167698
45 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123121_htm.xml XML 362746
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 22754231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services